An Interview With Cheryl Schwartz, Takeda's Senior Vice-President of US Rare Disease Business
Episode 70, Apr 04, 2023, 07:58 PM
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Cheryl Schwartz, Takeda's senior vice-president of US rare disease business, on the recent approval of lanadelumab-flyo (Takhzyro®) for hereditary angioedema.